FSDDF News and Press, FSD Pharma Inc - Class B

FSD Pharma Announces Closing of C$10.125 Million Private Placement to Institutional Investors Canada NewsWire TORONTO, June 9, 2020 TORONTO , June 9, 2020 /CNW/ -  FSD Pharma Inc.  (NASDAQ: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (the "Company") announces the cl...

FSD Pharma Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis Canada NewsWire TORONTO, June 3, 2020 TORONTO , June 3, 2020 /CNW/ -  FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: ...

FSD Pharma Monetizes Non-Core Asset with Sale of Partial Equity Stake in Pharmadrug Inc. Canada NewsWire TORONTO, May 21, 2020 - Buyer Holds Option to Purchase Additional Shares - TORONTO , May 21, 2020 /CNW/ - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE.CN) (FRA...

FSD Pharma Reports First Quarter 2020 Financial Results Canada NewsWire TORONTO, May 14, 2020 Provides Business Update TORONTO , May 14, 2020 /CNW/ - FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) ("FSD Pharma" or the "Company") today reported that...

FSD Pharma Takes Steps to Mitigate the Impact of COVID-19 on its Cannabis Production Facility in Cobourg, Ontario Canada NewsWire TORONTO, March 23, 2020 TORONTO , March 23, 2020 /CNW/ - FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) ("FSD Pharma" o...

FSD Pharma Begins Phase 1 In-human Safety and Tolerability Study of Ultra Micro-Palmitolylethanolamide (PEA) Canada NewsWire TORONTO, March 9, 2020 TORONTO , March 9, 2020 /CNW/ -  FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the ...

FSD Pharma Generates $7.7 Million in Proceeds and 670% Return on Investment through Sale of Interest in Cannara Biotech Canada NewsWire TORONTO, Feb. 20, 2020 TORONTO , Feb. 20, 2020 /CNW/ -  FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)  ("FS...

FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC Canada NewsWire TORONTO, Feb. 5, 2020 TORONTO , Feb. 5, 2020 /CNW/ - FSD Ph...

Seasoned Healthcare Executive and Academic Luminary Larry Kaiser, MD, Joins FSD Pharma Board of Directors Canada NewsWire TORONTO, Jan. 22, 2020 TORONTO , Jan. 22, 2020 /CNW/ - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)  ("FSD Pharma" or t...

FSD Pharma to Ring Nasdaq Opening Bell on Wednesday, January 22, 2020 Canada NewsWire TORONTO, Jan. 17, 2020 TORONTO , Jan. 17, 2020 /CNW/ - FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company") is pleased to announ...